1 Min Read
June 5 (Reuters) - Edwards Lifesciences Corp
* Edwards SAPIEN 3 valve receives FDA approval for aortic, mitral valve-in-valve procedures Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.